Skip to main content

Articles

Page 3 of 39

  1. Cardiovascular outcome trials of sodium-glucose co-transporter-2 inhibitors (SGLT2i CVOTs) found the agents to be associated with clinical benefits in terms of cardiovascular and renal outcomes. We performed a...

    Authors: Marco Castellana, Filippo Procino, Rodolfo Sardone, Pierpaolo Trimboli and Gianluigi Giannelli

    Citation: Cardiovascular Diabetology 2020 19:87

    Content type: Original investigation

    Published on:

  2. Type 2 diabetes (T2D) is associated with renal impairment and vascular endothelial dysfunction. Therefore, this pathological connection is an important therapeutic target. Recent cardiovascular and renal outco...

    Authors: Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada, Kazuhiro Sugimoto, Akira Kurozumi, Keiichi Torimoto, Hiroyuki Hirai and Koichi Node

    Citation: Cardiovascular Diabetology 2020 19:85

    Content type: Study protocol

    Published on:

  3. Left ventricular (LV) longitudinal dysfunction has been identified in type 2 diabetes mellitus (T2DM) patients with preserved LV ejection fraction (LVEF). However, the impact of T2DM on LV longitudinal functio...

    Authors: Hidekazu Tanaka, Kazuhiro Tatsumi, Hiroki Matsuzoe, Kensuke Matsumoto and Ken-ichi Hirata

    Citation: Cardiovascular Diabetology 2020 19:84

    Content type: Original investigation

    Published on:

  4. Current evidence about the cardiovascular safety of glucagon-like peptide-1 receptor agonist (GLP-1ra) possesses limited generalizability to real-world patients with type 2 diabetes (T2D) in usual practice. Th...

    Authors: Chun-Ting Yang, Chen-Yi Yang, Huang-Tz Ou and Shihchen Kuo

    Citation: Cardiovascular Diabetology 2020 19:83

    Content type: Original investigation

    Published on:

  5. Reactive hyperemia-peripheral arterial tonometry (RH-PAT) is a noninvasive and simple test for evaluating the endothelial function. There has been sparse evidence on the usefulness of the RH-PAT index (RHI) in...

    Authors: Bo Kyung Koo, Woo-Young Chung and Min Kyong Moon

    Citation: Cardiovascular Diabetology 2020 19:82

    Content type: Original investigation

    Published on:

  6. There is increasing concern regarding cardiovascular risk in individuals with non-alcoholic fatty liver disease. This study was conducted to evaluate whether hepatic steatosis with or without fibrosis is assoc...

    Authors: Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee and Kap Bum Huh

    Citation: Cardiovascular Diabetology 2020 19:81

    Content type: Original investigation

    Published on:

  7. The triglyceride-glucose index (TyG index) has been regarded as a reliable alternative marker of insulin resistance and an independent predictor of cardiovascular outcomes. Whether the TyG index predicts adver...

    Authors: Le Wang, Hong-liang Cong, Jing-xia Zhang, Yue-cheng Hu, Ao Wei, Ying-yi Zhang, Hua Yang, Li-bin Ren, Wei Qi, Wen-yu Li, Rui Zhang and Jing-han Xu

    Citation: Cardiovascular Diabetology 2020 19:80

    Content type: Original investigation

    Published on:

  8. Severe obesity among children and adolescents is a significant global public health concern. The prevalence has markedly increased over the last decades, becoming common in many countries. Overwhelming rates o...

    Authors: Cole D. Bendor, Aya Bardugo, Orit Pinhas-Hamiel, Arnon Afek and Gilad Twig

    Citation: Cardiovascular Diabetology 2020 19:79

    Content type: Review

    Published on:

  9. Bodyweight variability is a risk factor for atrial fibrillation (AF). We aimed to examine the relationship between bodyweight variability and the risk of AF in patients with type 2 diabetes mellitus (DM), and ...

    Authors: Hyun-Jung Lee, Eue-Keun Choi, Kyung-Do Han, Da Hye Kim, Euijae Lee, So-Ryoung Lee, Seil Oh and Gregory Y. H. Lip

    Citation: Cardiovascular Diabetology 2020 19:78

    Content type: Original investigation

    Published on:

  10. We aimed to investigate the hazard of hospitalization for heart failure (hHF) according to the transitions in metabolic health and obesity status.

    Authors: You-Bin Lee, Da Hye Kim, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Kyungdo Han and Hye Jin Yoo

    Citation: Cardiovascular Diabetology 2020 19:77

    Content type: Original investigation

    Published on:

  11. A possible association could exist between type 2 diabetes mellitus (T2DM) and Coronavirus-19 (Covid-19) infection. Indeed, patients with T2DM show high prevalence, severity of disease and mortality during Cov...

    Authors: Celestino Sardu, Giuseppe Gargiulo, Giovanni Esposito, Giuseppe Paolisso and Raffaele Marfella

    Citation: Cardiovascular Diabetology 2020 19:76

    Content type: Commentary

    Published on:

  12. Although an increased arterial stiffness has been associated with traditional coronary risk factors, the risk factors and pathology of arterial stiffness remain unclear. In this study, we aimed to identify the...

    Authors: Naoto Katakami, Kazuo Omori, Naohiro Taya, Shoya Arakawa, Mitsuyoshi Takahara, Taka-aki Matsuoka, Hiroshi Tsugawa, Masahiro Furuno, Takeshi Bamba, Eiichiro Fukusaki and Iichiro Shimomura

    Citation: Cardiovascular Diabetology 2020 19:75

    Content type: Original investigation

    Published on:

  13. Cardiovascular outcome trials in high-risk patients showed that some GLP-1 receptor agonists (GLP-1RA), but not dipeptidyl-peptidase-4 inhibitors (DPP-4i), can prevent cardiovascular events in type 2 diabetes ...

    Authors: Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro and Gian Paolo Fadini

    Citation: Cardiovascular Diabetology 2020 19:74

    Content type: Original investigation

    Published on:

  14. Clinical trials have shown the cardiovascular protective effect of sodium–glucose cotransporter-2 (SGLT2) inhibitors and reduced hospitalization for heart failure. However, no study has investigated the associ...

    Authors: Hung-Yi Chen, Jing-Yang Huang, Wun-Zhih Siao and Gwo-Ping Jong

    Citation: Cardiovascular Diabetology 2020 19:73

    Content type: Original investigation

    Published on:

  15. Endothelial Progenitor cells (EPCs) has been shown to be dysfunctional in both type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) leading to poor regeneration of endothelium and renal perfusion. ...

    Authors: Hassan B. Awal, Seshagiri Rao Nandula, Cleyton C. Domingues, Fiona J. Dore, Nabanita Kundu, Beda Brichacek, Mona Fakhri, Adrian Elzarki, Neeki Ahmadi, Shauna Safai, Magan Fosso, Richard L. Amdur and Sabyasachi Sen

    Citation: Cardiovascular Diabetology 2020 19:72

    Content type: Original investigation

    Published on:

  16. Postprandial hyperglycemia was reported to play a key role in established risk factors of coronary artery diseases (CAD) and cardiovascular events. Serum 1,5-anhydroglucitol (1,5-AG) levels are known to be a c...

    Authors: Gong Su, Ming-Xi Gao, Gen-Ling Shi, Xi-Xi Dai, Wei-Feng Yao, Tao Zhang and Shao-Wei Zhuang

    Citation: Cardiovascular Diabetology 2020 19:71

    Content type: Original investigation

    Published on:

  17. Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that collectively cause an increased risk of type 2 diabetes mellitus (T2DM) and nonatherosclerotic cardiovascular disease. This study aimed to...

    Authors: Yue Gao, Yan Ren, Ying-kun Guo, Xi Liu, Lin-jun Xie, Li Jiang, Meng-ting Shen, Ming-yan Deng and Zhi-gang Yang

    Citation: Cardiovascular Diabetology 2020 19:70

    Content type: Original investigation

    Published on:

  18. The effects of sodium-glucose cotransporter 2 inhibitor (SGLT2i) on cardiac function are not fully understood. We investigated the changes in cardiac function in diabetic patients according to the presence and...

    Authors: In-Chang Hwang, Goo-Yeong Cho, Yeonyee E. Yoon, Jin Joo Park, Jun-Bean Park, Seung-Pyo Lee, Hyung-Kwan Kim, Yong-Jin Kim and Dae-Won Sohn

    Citation: Cardiovascular Diabetology 2020 19:69

    Content type: Original investigation

    Published on:

  19. ABO blood groups have previously been associated with cardiovascular disease (CVD) in the general population. This study aimed to investigate the potential relationship between ABO blood groups and CVD in indi...

    Authors: Erika B. Parente, Valma Harjutsalo, Markku Lehto, Carol Forsblom, Niina Sandholm and Per-Henrik Groop

    Citation: Cardiovascular Diabetology 2020 19:68

    Content type: Original investigation

    Published on:

  20. We evaluated the effect of statin use on new-onset type 2 diabetes among individuals without atherosclerotic cardiovascular disease (ASCVD) using nationally representative South Korean claims data (2002–2013, ...

    Authors: Eonji Na, Sunyoung Cho, Dae Jung Kim, Junjeong Choi and Euna Han

    Citation: Cardiovascular Diabetology 2020 19:67

    Content type: Original investigation

    Published on:

  21. Empagliflozin showed efficacy in controlling glycaemia, leading to reductions in HbA1c levels, weight loss and blood pressure, compared to standard treatment. Moreover, the EMPA-REG OUTCOME trial demonstrated ...

    Authors: Jolanda Sabatino, Salvatore De Rosa, Laura Tammè, Claudio Iaconetti, Sabato Sorrentino, Alberto Polimeni, Chiara Mignogna, Andrea Amorosi, Carmen Spaccarotella, Masakazu Yasuda and Ciro Indolfi

    Citation: Cardiovascular Diabetology 2020 19:66

    Content type: Original investigation

    Published on:

  22. Type 2 diabetes mellitus is common in cardiovascular disease. It is associated with adverse clinical outcomes for patients who had undergone coronary artery bypass and valve operations. The aim of this study w...

    Authors: Shengwei Wang, Hao Cui, Keshan Ji, Changpeng Song, Changwei Ren, Hongchang Guo, Changsheng Zhu, Shuiyun Wang and Yongqiang Lai

    Citation: Cardiovascular Diabetology 2020 19:64

    Content type: Original investigation

    Published on:

  23. Evidence of adverse clinical outcomes for non-vitamin K antagonist oral anticoagulant (NOACs) and warfarin in patients with atrial fibrillation (AF) and diabetes mellitus are limited. We investigated the effec...

    Authors: Yi-Hsin Chan, Hsin-Fu Lee, Pei-Ru Li, Jia-Rou Liu, Tze-Fan Chao, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See and Gregory Y. H. Lip

    Citation: Cardiovascular Diabetology 2020 19:63

    Content type: Original investigation

    Published on:

  24. Sleep disturbance has been significantly associated with the incidence of cardiovascular disease (CVD) in the general population. However, despite the common prevalence of sleep disturbance in patients with ty...

    Authors: Young Choi and Jae Woo Choi

    Citation: Cardiovascular Diabetology 2020 19:61

    Content type: Original investigation

    Published on:

  25. Nationwide studies on contemporary trends in incidence of diabetes-related complications in Asia are lacking. We describe trends in incident coronary heart disease (CHD), stroke, heart failure, hyperglycaemic ...

    Authors: Hongjiang Wu, Eric S. H. Lau, Aimin Yang, Ronald C. W. Ma, Alice P. S. Kong, Elaine Chow, Wing-Yee So, Juliana C. N. Chan and Andrea O. Y. Luk

    Citation: Cardiovascular Diabetology 2020 19:60

    Content type: Original investigation

    Published on:

  26. To assess the prognostic role of coronary collaterals in patients with type 2 diabetes mellitus (T2DM) after successful percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).

    Authors: Zhen Kun Yang, Ying Shen, Yang Dai, Xiao Qun Wang, Jian Hu, Feng Hua Ding, Rui Yan Zhang, Lin Lu and Wei Feng Shen

    Citation: Cardiovascular Diabetology 2020 19:59

    Content type: Original investigation

    Published on:

  27. The triglyceride and glucose index (TyG) has been proposed as a marker of insulin resistance. This study aims to evaluate the association of the TyG index with the severity and mortality of coronavirus disease...

    Authors: Huihui Ren, Yan Yang, Fen Wang, Yongli Yan, Xiaoli Shi, Kun Dong, Xuefeng Yu and Shujun Zhang

    Citation: Cardiovascular Diabetology 2020 19:58

    Content type: Original investigation

    Published on:

  28. Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis. Previously we have shown that GLP-1 activates afferent renal nerve to increase efferent renal sympathetic nerve activity that negates the diure...

    Authors: Kenichi Katsurada, Shyam S. Nandi, Hong Zheng, Xuefei Liu, Neeru M. Sharma and Kaushik P. Patel

    Citation: Cardiovascular Diabetology 2020 19:57

    Content type: Original investigation

    Published on:

  29. The intracellular ROCK signaling pathway is an important modulator of blood pressure and of cardiovascular and renal remodeling when Rho-kinase activity is increased. Besides, in preclinical models of diabetes...

    Authors: Maria Paz Ocaranza, Patricio Valderas, Jackeline Moya, Luigi Gabrielli, Iván Godoy, Samuel Córdova, Paul Mac Nab, Lorena García, Luis Farías and Jorge E. Jalil

    Citation: Cardiovascular Diabetology 2020 19:56

    Content type: Original investigation

    Published on:

  30. The triglyceride-glucose (TyG) index is a marker of insulin resistance (IR) and has been associated with various metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases. However, limited inf...

    Authors: Ki-Woong Nam, Hyung-Min Kwon, Han-Yeong Jeong, Jin-Ho Park, Hyuktae Kwon and Su-Min Jeong

    Citation: Cardiovascular Diabetology 2020 19:53

    Content type: Original investigation

    Published on:

  31. The microvascular effects of obesity should be considered in diabetic individuals for elucidating underlying mechanisms and developing targeted therapies. This study aims to determine the effect of obesity on ...

    Authors: Li Jiang, Ke Shi, Ying-kun Guo, Yan Ren, Zhen-lin Li, Chun-chao Xia, Lei Li, Xi Liu, Lin-jun Xie, Yue Gao, Meng-ting Shen, Ming-yan Deng and Zhi-gang Yang

    Citation: Cardiovascular Diabetology 2020 19:52

    Content type: Original investigation

    Published on:

  32. Despite the known association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD), whether NAFLD predicts future CVD events, especially CVD mortality, remains uncertain. We evalu...

    Authors: Jun Hyung Kim, Jin Sil Moon, Seok Joon Byun, Jun Hyeok Lee, Dae Ryong Kang, Ki Chul Sung, Jang Young Kim and Ji Hye Huh

    Citation: Cardiovascular Diabetology 2020 19:51

    Content type: Original investigation

    Published on:

  33. The prognostic importance of an increased visit-to-visit blood pressure variability (BP-VVV) for the future development of micro- and macrovascular complications in type 2 diabetes has been scarcely investigat...

    Authors: Claudia R. L. Cardoso, Nathalie C. Leite and Gil F. Salles

    Citation: Cardiovascular Diabetology 2020 19:50

    Content type: Original investigation

    Published on:

  34. Although more than one-third of the patients with acute heart failure (AHF) have diabetes mellitus (DM), it is unclear if DM has an adverse impact on clinical outcomes. This study compared the outcomes in pati...

    Authors: Min Gyu Kong, Se Yong Jang, Jieun Jang, Hyun-Jai Cho, Sangjun Lee, Sang Eun Lee, Kye Hun Kim, Byung-Su Yoo, Seok-Min Kang, Sang Hong Baek, Dong-Ju Choi, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh…

    Citation: Cardiovascular Diabetology 2020 19:49

    Content type: Original investigation

    Published on:

  35. Exenatide, a glucagon like peptide 1 analog, has been suggested to reduce the cardiovascular disease risk factors, such as body weight, blood pressure and subclinical atherosclerosis in patients with type 2 di...

    Authors: Jie Zhang, Tong-Zhang Xian, Ming-Xiao Wu, Chen Li, Qi Pan and Li-Xin Guo

    Citation: Cardiovascular Diabetology 2020 19:48

    Content type: Original investigation

    Published on:

  36. The 5th Cardiovascular Outcome Trial (CVOT) Summit was held in Munich on October 24th–25th, 2019. As in previous years, this summit served as a reference meeting for in-depth discussions on the topic of recent...

    Authors: Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo JL Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck and Antonio Ceriello

    Citation: Cardiovascular Diabetology 2020 19:47

    Content type: Commentary

    Published on:

  37. The clear evidence of cardiovascular benefits in cardiovascular outcome trials of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in type 2 diabetes might suggest an effect on atherosclerotic plaque vulnera...

    Authors: Valentina Spigoni, Federica Fantuzzi, Cecilia Carubbi, Giulia Pozzi, Elena Masselli, Giuliana Gobbi, Anna Solini, Riccardo C. Bonadonna and Alessandra Dei Cas

    Citation: Cardiovascular Diabetology 2020 19:46

    Content type: Original investigation

    Published on:

  38. Elevation in small dense low-density lipoprotein (sdLDL) is common in patients with diabetes mellitus (DM), which has already been reported to be associated with incidence of coronary artery disease (CAD). The...

    Authors: Jing-Lu Jin, Hui-Wen Zhang, Ye-Xuan Cao, Hui-Hui Liu, Qi Hua, Yan-Fang Li, Yan Zhang, Na-Qiong Wu, Cheng-Gang Zhu, Rui-Xia Xu, Ying Gao, Xiao-Lin Li, Chuan-Jue Cui, Geng Liu, Jing Sun, Qian Dong…

    Citation: Cardiovascular Diabetology 2020 19:45

    Content type: Original investigation

    Published on:

  39. Growing evidences shows that fasting glucose target should be different according to their health condition in older adults with diabetes. However, there are limited data regarding the relationship between fas...

    Authors: Ji Hyun Lee, Kyungdo Han and Ji Hye Huh

    Citation: Cardiovascular Diabetology 2020 19:44

    Content type: Original investigation

    Published on:

  40. Microangiopathy in type 2 diabetes (T2D) is associated with cardiovascular disease (CVD), but most relevant studies were performed > 10 years ago. CVD risk factor management has since improved. The aim of this...

    Authors: Jocelyn J. Drinkwater, Timothy M. E. Davis, Valentina Hellbusch, Angus W. Turner, David G. Bruce and Wendy A. Davis

    Citation: Cardiovascular Diabetology 2020 19:43

    Content type: Original investigation

    Published on:

  41. Stress cardiovascular magnetic resonance (CMR) to screen for silent myocardial ischaemia in asymptomatic high risk patients with type 2 diabetes mellitus (DM) has never been performed, and its effectiveness is...

    Authors: Ming-Yen Ng, Wenli Zhou, Varut Vardhanabhuti, Chi-Ho Lee, Esther Yee Tak Yu, Eric Yuk Fai Wan, Kit Chan, Andrew T. Yan, Tai-Pang Ip, Kai-Hang Yiu and Bernd J. Wintersperger

    Citation: Cardiovascular Diabetology 2020 19:42

    Content type: Original investigation

    Published on:

  42. To assess the impact of changes in different glucose tolerance states on risk of incident cardiovascular disease (CVD)/coronary heart disease (CHD).

    Authors: Maryam Kabootari, Mitra Hasheminia, Fereidoun Azizi, Mohammadhassan Mirbolouk and Farzad Hadaegh

    Citation: Cardiovascular Diabetology 2020 19:41

    Content type: Original investigation

    Published on:

  43. Clinical and basic investigations have indicated a significant association between circulating growth differentiation factor 15 (GDF15) and cardiovascular disease; however, the relationship between GDF15 and l...

    Authors: Xingxing He, Jiaorong Su, Xiaojing Ma, Wei Lu, Wei Zhu, Yufei Wang, Yuqian Bao and Jian Zhou

    Citation: Cardiovascular Diabetology 2020 19:40

    Content type: Original investigation

    Published on:

  44. Although studies have shown that waist circumference (WC) is positively associated with an increased risk of cardiovascular diseases among the normal population, few studies have investigated WC in patients wi...

    Authors: Zhenhua Xing, Zhenyu Peng, Xiaopu Wang, Zhaowei Zhu, Junyu Pei, Xinqun Hu and Xiangping Chai

    Citation: Cardiovascular Diabetology 2020 19:39

    Content type: Original investigation

    Published on:

  45. Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis i...

    Authors: María Teresa Julián, Núria Alonso, Josep Lupón, Giovana Gavidia-Bovadilla, Elena Ferrer, Marta de Antonio, Jorge López-Ayerbe, Mar Domingo, Evelyn Santiago-Vacas, Elisabet Zamora, Pau Codina, Pedro Moliner, Julio Núñez, Javier Santesmases, Manel Puig-Domingo and Antoni Bayes-Genis

    Citation: Cardiovascular Diabetology 2020 19:38

    Content type: Original investigation

    Published on:

  46. Cardiovascular outcome trials (CVOTs) have demonstrated a significant reduction of major adverse cardiovascular events (MACE) in patients with type 2 diabetes (T2D) treated by SGLT-2 inhibitors. This holds tru...

    Authors: Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, Giuseppe Bellastella, Carlo Garofalo, Paolo Chiodini, Antonio Ceriello and Katherine Esposito

    Citation: Cardiovascular Diabetology 2020 19:35

    Content type: Commentary

    Published on:

Annual Journal Metrics